Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[250 Pages Report] The global hybrid grafts market is expected to reach a valuation of US$ 517.3 Mn by the end of 2022, and further expand at a CAGR of 5.20% in 2022-2032. As per the report, the market is likely to reach a valuation of ~US$ 858.7 Mn by the end of 2032.
Attribute | Key Statistics |
---|---|
Global Hybrid Grafts Market Estimated Size (2022E) | US$ 517.3 Mn |
Projected Market Valuation (2032F) | US$ 858.7 Mn |
Value-based CAGR (2022-2032) | 5.20% |
Collective Value Share: Top 5 Countries (2022E) | 51.50% |
Hybrid grafts are extensively manufactured for their unique capabilities in the field of surgery worldwide. These products are designed in such a way that they can easily challenge traditional surgical procedures.
Hybrid grafts are set to be used for those patients having a small hamstring auto graft diameter. They enable surgeons to accelerate the overall size of grafts and develop a graft diameter of around 8mm or more.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global hybrid grafts market exhibited a CAGR of approximately 16.6% and reached a valuation of ~US$ 2.96 Bn in the global vascular grafts market in 2021.
Demand for hybrid grafts will continue to grow with increasing number of cardiac and vascular surgeries across the globe. With the emergence of technologically advanced methods and instruments, need for minimally invasive procedures is likely to surge at a rapid pace.
Minimally invasive procedures can reduce the physical and economic burden placed on patients by enabling a shorter stay in intensive care units or hospitals. The recovery rate is also faster than that of traditional surgical procedures. Patients who are unable to undergo open surgeries due to complications can easily opt for hybrid graft as it is minimally invasive and less painful.
Prevalence of aortic aneurysms (AAs) has increased in the last two decades owing to growing aging population, increasing number of smokers, implementation of screening programs, and availability of improved diagnostic methods. According to the CDC, in 2019, about 9,904 deaths in the U.S. occurred due to aortic aneurysms or aortic dissections.
Moreover, peripheral arterial disease (PAD) affects nearly 12%–14% of the general population. Its incidence rises with age, with up to 20% of individuals above the age of 75 suffering from the disease. Some of the major risk factors for PAD include smoking, hyperlipidemia, hypertension, diabetes, and metabolic syndrome.
Males and the elderly are more likely to develop PAD. High level of cholesterol is another crucial factor that may lead to PAD among the geriatric population.
Thus, increasing prevalence of PAD and AAs across the globe is projected to help the global hybrid grafts market to grow at a CAGR of 5.20% during the forecast period from 2022 to 2032.
The global hybrid grafts market is set to create new growth opportunities owing to ongoing development of novel thoracic aortic grafts. Increasing burden of chronic diseases is also expected to drive the market in the upcoming decade.
Rising number of health issues such as high cholesterol and blood pressure among the aging population is set to result in aortic aneurysms. Development of aortic aneurysms is projected to make them more vulnerable to contracting diseases, thereby pushing demand for hybrid grafts.
Cases of sudden injuries are also very common among the aging population. Surging prevalence of cancer and cardiovascular diseases is another vital factor that would contribute to the growth.
As per the WHO, about 17.9 million people die every year because of cardiovascular diseases worldwide and nearly 85% of all deaths associated with cardiovascular diseases are due to strokes and heart attacks. Increasing adoption of minimally invasive procedures on the back of enhanced recovery rates and low hospital stays is thus estimated to propel the global hybrid grafts market.
Graft rejection is considered to be one of the major drawbacks in the global hybrid grafts market. Prevalence of graft rejection is projected to grow at a fast pace as medication management is unable to prevent the same.
High cost of endovascular aneurysm repair treatments is another concern in the global market. Cost of treatment is likely to be unaffordable for a huge percentage of the middle- and lower-middle-class community. Spurred by the aforementioned limitations, demand for hybrid grafts may decline in the forthcoming years.
“Key Players Are Developing Thoracic Aortic Grafts in the U.S.”
The U.S. held approximately 38.2% of the global hybrid grafts market share in 2021. Presence of favourable reimbursement policies and increasing incidence of aortic aneurysm are projected to drive the market in the country.
Further, higher adoption of smoking habits and surging dependence on minimally invasive procedures are contributing to the growth in the United States. Companies in the U.S. are also focusing on the development of thoracic aortic grafts to meet the ever-increasing demand from patients, which would aid growth.
“Rising Prevalence of Cardiac and Vascular Diseases to Drive Germany”
Germany held a share of about 3.5% in 2021 and is projected to dominate the global hybrid grafts market in the assessment period. Expansion of the healthcare sector, increasing male geriatric population, advancements in minimally invasive procedures, and rising patient pool suffering from cardiac and vascular diseases are anticipated to drive growth.
As per a 2018 study conducted by the German Federal Statistical Office, incidence of thoracic aortic aneurysm repair has grown in Germany. Aneurysms were found in around 48,098 individuals and the age accounted was above 69, with 65.2 percent of the population being male.
Hypertension (74.9%), coronary heart disease (26.2%),peripheral artery disease (particularly abdominal aortic aneurysm, 42.6%), and other heart illnesses (41.6%) were the most common comorbidities that were found in the country.
Increasing number of endovascular repairing procedures that are conducted to combat the prevalence of aneurysm is another significant factor that would create high demand for hybrid grafts in Germany.
“Hybrid Grafts to Be Used for Endovascular Aneurysm Repair Procedures”
China hybrid grafts market is estimated to generate nearly 3.8% of share during the forecast period (2022-2032). Ongoing development of the country’s healthcare industry with the addition of innovative products and high patient holding capacity is expected to bode well for the market.
Easy availability of premium quality, yet cost-effective medical instruments in China is also likely to push the market. Increasing number of endovascular aneurysm repair (EVAR) procedures in the country is another vital factor that would aid sales of hybrid grafts.
Moreover, leading Chinese medical device companies are aiming to enter untapped areas for increasing their sales, which would further accelerate growth in the hybrid grafts market in China during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Thoracic Aortic Grafts to Gain Impetus with Prevalence of Chronic Diseases”
Based on product, the thoracic aortic grafts segment is expected to exhibit high growth at a CAGR of 5.6% in the forecast period and hold a share of about 78.2% in the global hybrid grafts market in 2032. Thoracic aortic grafts are gaining traction due to rising prevalence of various chronic diseases with the adoption of unhealthy lifestyles.
Recent developments and modifications in the field of thoracic aortic grafts on the back of changing raw materials and processing techniques are further expected to boost growth of the segment in the global hybrid grafts market.
“Hospitals to Conduct More Surgical Procedures in Future”
Based on end user, hospitals held the highest hybrid grafts market share of 59.2% in 2021. Growing prevalence of cardiac and vascular diseases, as well as increasing number of surgical procedures would drive the segment, thereby propelling sales of hybrid grafts in the evaluation period.
The global hybrid grafts market is moderately fragmented with the presence of various key players. To meet the high consumer demand and expand their customer base, these companies are developing new materials and manufacturing techniques.
Some of the recent industry developments by key players in the hybrid grafts market are given below:
Attribute | Details |
---|---|
Estimated Market Size (2022) | US$ 517.3 Mn |
Projected Market Valuation (2032) | US$ 858.7 Mn |
Value-based CAGR (2022-2032) | 5.20% |
Forecast Period | 2022-2032 |
Historical Data Available for | 2017-2021 |
Market Analysis | US$ Mn for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered | U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, Egypt, GCC, and South Africa |
Key Market Segments Covered | Product, End User, and Region |
Key Companies Profiled |
|
Report Coverage | Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
The global hybrid grafts market was worth US$ 491.7 Mn in 2021 and is set to expand 1.7x over the next ten years.
The hybrid grafts market is expected to reach US$ 858.7 Mn by the end of 2032 and register 5.20% CAGR.
Growing awareness about minimally invasive procedures, rising geriatric population, risks associated with open surgery, and high prevalence of cardiac & vascular diseases are some of the key trends in the market.
The U.S., China, Germany, the U.K., and India are expected to drive demand for hybrid grafts.
The U.S. accounted for about 38.2% of the North America hybrid grafts market share in 2021.
Europe hybrid grafts market is projected to exhibit growth at a CAGR of 8.1% over the next ten years.
The U.S., Germany, and China are the key producers of hybrid grafts.
Terumo Corporation, BD Interventional, Getinge AB, Merit Medical Systems, Inc., and JOTEC GmbH are some of the key players in the hybrid grafts market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption/ Usage Analysis 4.2. Product Innovation and Market Sustainability Analysis 4.3. Value Chain Analysis 4.4. Key Promotional Strategies, By Manufacturers 4.5. PESTLE Analysis 4.6. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Market Growth Outlook 5.1.2. Global Vascular Grafts Market Overview 5.1.3. Global GDP and Infrastructure Investment 5.2. Forecast Factors - Relevance & Impact 5.2.1. High Geriatric Population 5.2.2. Prevalence of Smoking 5.2.3. Increasing Number of Screening Methods 5.2.4. Adoption of Minimally-Invasive Procedures 5.2.5. Awareness related to the Risk of Open Surgery 5.2.6. Rules and Regulatory Scenarios 5.2.7. Government Funding 5.2.8. Strengthening Research and Development 5.3. Value Chain 5.3.1. Raw Material Suppliers 5.3.2. Product Manufacturers 5.3.3. End Users 5.4. COVID-19 Crisis – Impact Assessment 5.4.1. Current Statistics 5.4.2. Short-Mid-Long Term Outlook 5.4.3. Likely Rebound 5.5. Market Dynamics 5.5.1. Drivers 5.5.2. Restraints 5.5.3. Opportunity Analysis 5.6. Global Supply Demand Analysis 6. Global Hybrid Grafts Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032 6.1. Historical Market Volume (Units) Analysis, 2017–2021 6.2. Current and Future Market Size (US$ Mn) and Forecast Projections, 2022–2032 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Hybrid Grafts Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Global Average Pricing Analysis Benchmark 8. Global Hybrid Grafts Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032 8.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 8.2. Current and Future Market Size (US$ Mn) and Forecast Projections, 2022–2032 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Mn) and Volume(Units) Analysis and By Product, 2017–2021 9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032 9.3.1. Thoracic Aortic Graft 9.3.2. Peripheral Vascular Graft 9.4. Market Attractiveness Analysis By Product 10. Global Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032, By End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021 10.3. Current and Future Market Size (US$ Mn) and Forecast By End User, 2022–2032 10.3.1. Hospitals 10.3.2. Ambulatory Surgical Centers 10.4. Market Attractiveness Analysis By End User 11. Global Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021 11.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. South Asia 11.3.5. East Asia 11.3.6. Oceania 11.3.7. Middle East & Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021 12.4. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product, 2022–2032 12.4.1. By Country 12.4.1.1. U.S. 12.4.1.2. Canada 12.4.2. By Product 12.4.3. By End User 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product 12.5.3. By End User 12.6. Market Trends 12.7. Key Market Participants - Intensity Mapping 12.8. Drivers and Restraints - Impact Analysis 12.9. Country Level Analysis & Forecast 12.9.1. U.S. Hybrid Grafts Market 12.9.1.1. Introduction 12.9.1.2. Market Analysis and Forecast by Market Taxonomy 12.9.1.2.1. By Product 12.9.1.2.2. By End User 12.9.2. Canada Hybrid Grafts Market 12.9.2.1. Introduction 12.9.2.2. Market Analysis and Forecast by Market Taxonomy 12.9.2.2.1. By Product 12.9.2.2.2. By End User 13. Latin America Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021 13.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Argentina 13.4.1.4. Rest of Latin America 13.4.2. By Product 13.4.3. By End User 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product 13.5.3. By End User 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 13.9. Country Level Analysis & Forecast 13.9.1. Brazil Hybrid Grafts Market 13.9.1.1. Introduction 13.9.1.2. Market Analysis and Forecast by Market Taxonomy 13.9.1.2.1. By Product 13.9.1.2.2. By End User 13.9.2. Mexico Hybrid Grafts Market 13.9.2.1. Introduction 13.9.2.2. Market Analysis and Forecast by Market Taxonomy 13.9.2.2.1. By Product 13.9.2.2.2. By End User 13.9.3. Argentina Hybrid Grafts Market 13.9.3.1. Introduction 13.9.3.2. Market Analysis and Forecast by Market Taxonomy 13.9.3.2.1. By Product 13.9.3.2.2. By End User 14. Europe Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021 14.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. Italy 14.4.1.3. France 14.4.1.4. U.K. 14.4.1.5. Spain 14.4.1.6. BENELUX 14.4.1.7. Nordic Countries 14.4.1.8. Russia 14.4.1.9. Rest of Europe 14.4.2. By Product 14.4.3. By End User 14.5. Market Attractiveness Analysis 14.5.1. By Product 14.5.2. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 14.9. Country Level Analysis & Forecast 14.9.1. Germany Hybrid Grafts Market 14.9.1.1. Introduction 14.9.1.2. Market Analysis and Forecast by Market Taxonomy 14.9.1.2.1. By Product 14.9.1.2.2. By End User 14.9.2. France Hybrid Grafts Market 14.9.2.1. Introduction 14.9.2.2. Market Analysis and Forecast by Market Taxonomy 14.9.2.2.1. By Product 14.9.2.2.2. By End User 14.9.3. Italy Hybrid Grafts Market 14.9.3.1. Introduction 14.9.3.2. Market Analysis and Forecast by Market Taxonomy 14.9.3.2.1. By Product 14.9.3.2.2. By End User 14.9.4. Spain Hybrid Grafts Market 14.9.4.1. Introduction 14.9.4.2. Market Analysis and Forecast by Market Taxonomy 14.9.4.2.1. By Product 14.9.4.2.2. By End User 14.9.5. U.K. Hybrid Grafts Market 14.9.5.1. Introduction 14.9.5.2. Market Analysis and Forecast by Market Taxonomy 14.9.5.2.1. By Product 14.9.5.2.2. By End User 14.9.6. Benelux Union Hybrid Grafts Market 14.9.6.1. Introduction 14.9.6.2. Market Analysis and Forecast by Market Taxonomy 14.9.6.2.1. By Product 14.9.6.2.2. By End User 14.9.7. Nordic Countries Hybrid Grafts Market 14.9.7.1. Introduction 14.9.7.2. Market Analysis and Forecast by Market Taxonomy 14.9.7.2.1. By Product 14.9.7.2.2. By End User 14.9.8. Russia Hybrid Grafts Market 14.9.8.1. Introduction 14.9.8.2. Market Analysis and Forecast by Market Taxonomy 14.9.8.2.1. By Product 14.9.8.2.2. By End User 15. South Asia Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021 15.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032 15.4.1. By Country 15.4.1.1. India 15.4.1.2. Thailand 15.4.1.3. Indonesia 15.4.1.4. Malaysia 15.4.1.5. Rest of South Asia 15.4.2. By Product 15.4.3. By End User 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product 15.5.3. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 15.9. Country Level Analysis & Forecast 15.9.1. India Hybrid Grafts Market 15.9.1.1. Introduction 15.9.1.2. Market Analysis and Forecast by Market Taxonomy 15.9.1.2.1. By Product 15.9.1.2.2. By End User 15.9.2. Indonesia Hybrid Grafts Market 15.9.2.1. Introduction 15.9.2.2. Market Analysis and Forecast by Market Taxonomy 15.9.2.2.1. By Product 15.9.2.2.2. By End User 15.9.3. Malaysia Hybrid Grafts Market 15.9.3.1. Introduction 15.9.3.2. Market Analysis and Forecast by Market Taxonomy 15.9.3.2.1. By Product 15.9.3.2.2. By End User 15.9.4. Thailand Hybrid Grafts Market 15.9.4.1. Introduction 15.9.4.2. Market Analysis and Forecast by Market Taxonomy 15.9.4.2.1. By Product 15.9.4.2.2. By End User 16. East Asia Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021 16.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032 16.4.1. By Country 16.4.1.1. China 16.4.1.2. Japan 16.4.1.3. South Korea 16.4.2. By Product 16.4.3. By End User 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product 16.5.3. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 16.9. Country Level Analysis & Forecast 16.9.1. China Hybrid Grafts Market 16.9.1.1. Introduction 16.9.1.2. Market Analysis and Forecast by Market Taxonomy 16.9.1.2.1. By Product 16.9.1.2.2. By End User 16.9.2. Japan Hybrid Grafts Market 16.9.2.1. Introduction 16.9.2.2. Market Analysis and Forecast by Market Taxonomy 16.9.2.2.1. By Product 16.9.2.2.2. By End User 16.9.3. South Korea Hybrid Grafts Market 16.9.3.1. Introduction 16.9.3.2. Market Analysis and Forecast by Market Taxonomy 16.9.3.2.1. By Product 16.9.3.2.2. By End User 17. Oceania Hybrid Grafts Market Analysis 2017-2021 and Forecast 2022–2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021 17.3. Current and Future Market Size (US$ Mn) and Volume(Units) Analysis and Forecast By Product, 2022–2032 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By End User 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. Australia Hybrid Grafts Market 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By End User 17.8.2. New Zealand Hybrid Grafts Market 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By End User 18. Middle East and Africa (MEA) Hybrid Grafts Market Analysis 2017-2021 and Forecast 2022–2032 18.1. Introduction 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Turkey 18.3.1.3. Egypt 18.3.1.4. Israel 18.3.1.5. South Africa 18.3.1.6. North Africa 18.3.1.7. Rest of Middle East and Africa 18.3.2. By Product 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Product 18.4.2. By End User 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. GCC Countries Hybrid Grafts Market 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By End User 18.8.2. Egypt Hybrid Grafts Market 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By End User 18.8.3. Turkey Hybrid Grafts Market 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast by Market Taxonomy 18.8.3.2.1. By Product 18.8.3.2.2. By End User 18.8.4. South Africa Hybrid Grafts Market 18.8.4.1. Introduction 18.8.4.2. Market Analysis and Forecast by Market Taxonomy 18.8.4.2.1. By Product 18.8.4.2.2. By End User 18.8.5. North Africa Hybrid Grafts Market 18.8.5.1. Introduction 18.8.5.2. Market Analysis and Forecast by Market Taxonomy 18.8.5.2.1. By Product 18.8.5.2.2. By End User 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Share Analysis of Top Players 19.3. Market Presence Analysis 19.3.1. By Regional Footprint of Players 19.3.2. Product Footprint of Players 19.3.3. Channel Footprint of Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Terumo Corporation 20.3.1.1. Overview 20.3.1.2. Product Portfolio 20.3.1.3. Key Financials 20.3.1.4. SWOT Analysis 20.3.1.5. Sales Footprint 20.3.1.6. Strategy Overview 20.3.1.6.1. Marketing Strategy 20.3.1.6.2. Product Strategy 20.3.1.6.3. Channel Strategy 20.3.2. BD Interventional 20.3.2.1. Overview 20.3.2.2. Product Portfolio 20.3.2.3. Key Financials 20.3.2.4. SWOT Analysis 20.3.2.5. Sales Footprint 20.3.2.6. Strategy Overview 20.3.2.6.1. Marketing Strategy 20.3.2.6.2. Product Strategy 20.3.2.6.3. Channel Strategy 20.3.3. Getinge AB 20.3.3.1. Overview 20.3.3.2. Product Portfolio 20.3.3.3. Key Financials 20.3.3.4. SWOT Analysis 20.3.3.5. Sales Footprint 20.3.3.6. Strategy Overview 20.3.3.6.1. Marketing Strategy 20.3.3.6.2. Product Strategy 20.3.3.6.3. Channel Strategy 20.3.4. Merit Medical Systems, Inc. 20.3.4.1. Overview 20.3.4.2. Product Portfolio 20.3.4.3. Key Financials 20.3.4.4. SWOT Analysis 20.3.4.5. Sales Footprint 20.3.4.6. Strategy Overview 20.3.4.6.1. Marketing Strategy 20.3.4.6.2. Product Strategy 20.3.4.6.3. Channel Strategy 20.3.5. JOTEC GmbH 20.3.5.1. Overview 20.3.5.2. Product Portfolio 20.3.5.3. Key Financials 20.3.5.4. SWOT Analysis 20.3.5.5. Sales Footprint 20.3.5.6. Strategy Overview 20.3.5.6.1. Marketing Strategy 20.3.5.6.2. Product Strategy 20.3.5.6.3. Channel Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Global Hybrid Grafts Market Size Volume (Units) Analysis 2017-2021 and Forecast, 2022-2032, By Product Table 02: Global Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product Table 03: Global Hybrid Grafts Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022-2032, By End User Table 04: Global Hybrid Grafts Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Region Table 05: North America Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 06: North America Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product Table 07: North America Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 08: Latin America Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 09: Latin America Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product Table: Latin America Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 10: Europe Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 11: Europe Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product Table 12: Europe Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 13: South Asia Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 14: South Asia Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product Table 15: South Asia Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 16: East Asia Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 17: East Asia Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product Table 18: East Asia Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 19: Oceania Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 20: Oceania Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product Table 21: Oceania Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 22: Middle East & Africa Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 23: Middle East & Africa Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product Table 24: Middle East & Africa Hybrid Grafts Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Figure 01: Global Hybrid Grafts Market, By Product, 2022E Figure 02: Global Hybrid Grafts Market, By End User, 2022E Figure 03: Global Hybrid Grafts Market, By Region, 2022E Figure 04: Hybrid Grafts Market Size (US$ Mn) Analysis, 2017-2021 Figure 05: Global Hybrid Grafts Market Size (US$ Mn) & Y-o-Y Growth (%), Analysis, 2022-2032 Figure 06: Global Hybrid Grafts Market Absolute $ Opportunity Analysis, 2022-2032 Figure 07: Global Hybrid Grafts Market Analysis by Product–2022 & 2032 Figure 08: Global Hybrid Grafts Market Y-o-Y Growth Projections by Product, 2022-2032 Figure 09: Global Hybrid Grafts Market Attractiveness Analysis, By Product Figure 10: Global Hybrid Grafts Market Analysis by End User–2022 & 2032 Figure 11: Global Hybrid Grafts Market Y-o-Y Growth (%) By End User, 2022-2032 Figure 12: Global Hybrid Grafts Market Attractiveness Analysis, By End User Figure 13: Global Hybrid Grafts Market Share Analysis (%) by Region, 2022 & 2032 Figure 14: Global Hybrid Grafts Market Y-o-Y Growth (%) by Region, 2022–2032 Figure 15: Global Hybrid Grafts Market Attractiveness Analysis, By Region Figure 16: North America Hybrid Grafts Market Value Share, By Country (2022F) Figure 17: North America Hybrid Grafts Market Value Share, By Product (2022E) Figure 18: North America Hybrid Grafts Market Value Share, By End User (2022E) Figure 19: North America Hybrid Grafts Market Size (US$ Mn) Analysis, 2017-2021 Figure 20: North America Hybrid Grafts Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 21: North America Hybrid Grafts Market Attractiveness Analysis, By Product Figure 22: North America Hybrid Grafts Market Attractiveness Analysis, By End User Figure 23: North America Hybrid Grafts Market Attractiveness Analysis, By Country Figure 24: Latin America Hybrid Grafts Market Value Share, By Country (2022F) Figure 25: Latin America Hybrid Grafts Market Value Share, By Product (2022E) Figure 26: Latin America Hybrid Grafts Market Value Share, By End User (2022E) Figure 27: Latin America Hybrid Grafts Market Size (US$ Mn) Analysis, 2017-2021 Figure 28: Latin America Hybrid Grafts Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 29: Latin America Hybrid Grafts Market Attractiveness Analysis, By Product Figure 30: Latin America Hybrid Grafts Market Attractiveness Analysis, By End User Figure 31: Latin America Hybrid Grafts Market Attractiveness Analysis, By Country Figure 32: Europe Hybrid Grafts Market Value Share, By Country (2022F) Figure 33: Europe Hybrid Grafts Market Value Share, By Product (2022E) Figure 34: Europe Hybrid Grafts Market Value Share, By End User (2022E) Figure 35: Europe Hybrid Grafts Market Size (US$ Mn) Analysis, 2017-2021 Figure 36: Europe Hybrid Grafts Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 37: Europe Hybrid Grafts Market Attractiveness Analysis, By Product Figure 38: Europe Hybrid Grafts Market Attractiveness Analysis, By End User Figure 39: Europe Hybrid Grafts Market Attractiveness Analysis, By Country Figure 40: South Asia Hybrid Grafts Market Value Share, By Country (2022F) Figure 41: South Asia Hybrid Grafts Market Value Share, By Product (2022E) Figure 42: South Asia Hybrid Grafts Market Value Share, By End User (2022E) Figure 43: South Asia Hybrid Grafts Market Size (US$ Mn) Analysis, 2017-2021 Figure 44: South Asia Hybrid Grafts Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 45: South Asia Hybrid Grafts Market Attractiveness Analysis, By Product Figure 46: South Asia Hybrid Grafts Market Attractiveness Analysis, By End User Figure 47: South Asia Hybrid Grafts Market Attractiveness Analysis, By Country Figure 48: East Asia Hybrid Grafts Market Value Share, By Country (2022E) Figure 49: East Asia Hybrid Grafts Market Value Share, By Products (2022E) Figure 50: East Asia Hybrid Grafts Market Value Share, By End User (2022E) Figure 51: East Asia Hybrid Grafts Market Size (US$ Mn) Analysis, 2017-2021 Figure 52: East Asia Hybrid Grafts Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 53: East Asia Hybrid Grafts Market Attractiveness Analysis, By Product Figure 54: East Asia Hybrid Grafts Market Attractiveness Analysis, By End User Figure 55: East Asia Hybrid Grafts Market Attractiveness Analysis, By Country Figure 56: Oceania Hybrid Grafts Market Value Share, By Country (2022E) Figure 57: Oceania Hybrid Grafts Market Value Share, By Product (2022E) Figure 58: Oceania Hybrid Grafts Market Value Share, By End User (2022E) Figure 59: Oceania Hybrid Grafts Market Size (US$ Mn) Analysis, 2017-2021 Figure 60: Oceania Hybrid Grafts Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 61: Oceania Hybrid Grafts Market Attractiveness Analysis, By Product Figure 62: Oceania Hybrid Grafts Market Attractiveness Analysis, By End User Figure 63: Oceania Hybrid Grafts Market Attractiveness Analysis, By Country Figure 64: Middle East & Africa Hybrid Grafts Market Value Share, By Country (2022E) Figure 65: Middle East & Africa Hybrid Grafts Market Value Share, By Product (2022E) Figure 66: Middle East & Africa Hybrid Grafts Market Value Share, By End User (2022E) Figure 67: Middle East & Africa Hybrid Grafts Market Size (US$ Mn) Analysis, 2017-2021 Figure 68: Middle East & Africa Hybrid Grafts Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 69: Middle East & Africa Hybrid Grafts Market Attractiveness Analysis, By Product Figure 70: Middle East & Africa Hybrid Grafts Market Attractiveness Analysis, By End User Figure 71: Middle East & Africa Hybrid Grafts Market Attractiveness Analysis, By Country Figure 72: Market value Proportion Analysis, By Key Countries Figure 73: Global Vs. Country Growth Comparison Figure 74: U.S. Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 75: U.S. Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 76: Canada Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 77: Canada Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 78: Brazil Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 79: Brazil Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 80: Mexico Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 81: Mexico Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 82: Argentina Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 83: Argentina Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 84: Germany Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 85: Germany Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 86: Italy Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 87: Italy Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 88: France Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 89: France Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 90: U.K. Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 91: U.K. Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 92: Spain Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 93: Spain Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 94: BENELUX Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 95: BENELUX Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 96: Nordic Countries Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 97: Nordic Countries Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 98: Russia Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 99: Russia Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 100: India Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 101: India Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 102: Thailand Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 103: Thailand Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 104: Indonesia Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 105: Indonesia Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 106: Malaysia Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 107: Malaysia Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 108: China Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 109: China Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 110: Japan Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 111: Japan Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 112: South Korea Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 113: South Korea Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 114: Australia Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 115: Australia Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 116: New Zealand Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 117: New Zealand Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 118: GCC Countries Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 119: GCC Countries Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 120: Turkey Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 121: Turkey Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 122: Egypt Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 123: Egypt Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 124: South Africa Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 125: South Africa Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032 Figure 126: Northern Africa Hybrid Grafts Market Share Analysis (%) by Product, 2022 & 2032 Figure 127: Northern Africa Hybrid Grafts Market Share Analysis (%) by End User, 2022 & 2032
Recommendations
Explore Healthcare Insights
View Reports